DRI expects to launch Fund III later this year
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
Copyright PEI Media
Not for publication, email or dissemination